Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 13, 2025 • 7:30 AM ET

Date/Time Source News Release
05/13/2025 04:30 PM EDT GlobeNewswire MeiraGTx Announces the Presentation of Four Posters at the American Society of Gene and Cell Therapy (ASGCT) 2025 Annual Meeting
05/13/2025 08:00 AM EDT GlobeNewswire MeiraGTx Reports First Quarter 2025 Financial and Operational Results
05/09/2025 08:00 AM EDT GlobeNewswire MeiraGTx Granted FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for AAV-GAD for the Treatment of Parkinson's Disease
03/13/2025 08:00 AM EDT GlobeNewswire MeiraGTx Reports Fourth Quarter and Full Year 2024 Financial and Operational Results and Recent Business Updates
03/13/2025 07:30 AM EDT GlobeNewswire MeiraGTx Enters into a Strategic Collaboration with Hologen AI to Expedite Phase 3 Development of AAV-GAD for Parkinson's Disease and Industrialize MeiraGTx's Proprietary Manufacturing Process
02/21/2025 06:30 AM EST GlobeNewswire MeiraGTx Announces The Lancet Publication of Data Demonstrating the Efficacy of rAAV8.hRKp.AIPL1 for the Treatment of Leber Congenital Amaurosis 4 (LCA4) Retinal Dystrophy
01/22/2025 08:30 AM EST GlobeNewswire MeiraGTx Receives Rare Pediatric Disease Designation from FDA for AAV8-RK-RetGC for the Treatment of Patients with Leber Congenital Amaurosis due to GUCY2D Mutations
12/09/2024 08:00 AM EST GlobeNewswire MeiraGTx Granted FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for AAV2-hAQP1 for the Treatment of Grade 2/3 Radiation-Induced Xerostomia
11/24/2024 07:27 PM EST PR Newswire Ascentage Pharma Appoints Ms. Marina S. Bozilenko and Dr. Debra Yu as Independent Non-Executive Directors
11/13/2024 08:00 AM EST GlobeNewswire MeiraGTx Announces Third Quarter 2024 Financial and Operational Results and Recent Business Updates
Page

Additional News

As of June 13, 2025 • 7:30 AM ET

Date/Time Source News Release
05/28/2025 01:44 PM EDT Stock Traders Daily (MGTX) Technical Data
05/13/2025 09:15 AM EDT Zacks MeiraGTx Holdings PLC (MGTX) Reports Q1 Loss, Misses Revenue Estimates
05/13/2025 08:19 AM EDT SeekingAlpha MeiraGTx GAAP EPS of -$0.51, revenue of $1.93M
05/09/2025 10:53 AM EDT SeekingAlpha MeiraGTx gets FDA RMAT status for its Parkinson's disease treatment
05/08/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Thursday, May 8th, 2025
05/08/2025 05:31 AM EDT US Earnings Reports Expected earnings - MeiraGTx Holdings plc
05/07/2025 04:30 PM EDT Stock Traders Daily How the (MGTX) price action is used to our Advantage
04/22/2025 09:52 AM EDT Stock Traders Daily Objective long/short (MGTX) Report
04/10/2025 09:49 AM EDT Zacks Beam Therapeutics (BEAM) Moves 12.6% Higher: Will This Strength Last?
03/25/2025 10:50 AM EDT SeekingAlpha MeiraGTx Holdings: Gaining Regulatory Focus
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.